Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Cerilliant
Chinese Patent Office
UBS
Deloitte
Merck
Healthtrust
Express Scripts
Fish and Richardson

Generated: July 18, 2018

DrugPatentWatch Database Preview

Clavulanate potassium; ticarcillin disodium - Generic Drug Details

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

What are the generic drug sources for clavulanate potassium; ticarcillin disodium and what is the scope of clavulanate potassium; ticarcillin disodium patent protection?

Clavulanate potassium; ticarcillin disodium
is the generic ingredient in two branded drugs marketed by Glaxosmithkline and is included in three NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-seven drug master file entries for clavulanate potassium; ticarcillin disodium.
Summary for clavulanate potassium; ticarcillin disodium
US Patents:0
Tradenames:2
Applicants:1
NDAs:3
Drug Master File Entries: 27
Clinical Trials: 1
DailyMed Link:clavulanate potassium; ticarcillin disodium at DailyMed

US Patents and Regulatory Information for clavulanate potassium; ticarcillin disodium

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050590-001 Apr 1, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 062691-001 Dec 19, 1986 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline TIMENTIN clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050590-002 Apr 1, 1985 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Glaxosmithkline TIMENTIN IN PLASTIC CONTAINER clavulanate potassium; ticarcillin disodium INJECTABLE;INJECTION 050658-001 Dec 15, 1989 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Queensland Health
US Department of Justice
McKinsey
Deloitte
Covington
Cipla
Cantor Fitzgerald
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.